LABD
Direxion Daily S&P Biotech Bear 3X ETF·ARCA
--
--(--)
--
--(--)
Direxion Daily S&P Biotech Bear 3X ETF Fundamentals
Assets Under Management
91.66MUSD
Fund Flows (1Y)
--
Dividend Yield (TTM)
7.14%
Discount/Premium to NAV
--
Shares Outstanding
--
Expense Ratio
1.07%
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | +12.45% | +7.25% | +0.38% | -72.43% | -91.02% | -89.86% |
NAV Total Return | +15.41% | +7.90% | -3.20% | -72.62% | -89.01% | -87.20% |
Ratings
Aime Ratings
No data is currently available
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Top 10 Holdings
Symbol
Ratio
GOLDMAN FINL SQ TRSRY INST 506
40.24%
DREYFUS GOVT CASH MAN INS
36.44%
GOLDMAN SACHS FIN GOV 465 INSTITUT
9.13%
DREYFUS TRSRY SECURITIES CASH MGMT
3.27%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
-2.46%
Top 10 Weight 86.62%
5 Total Holdings
Is SPY better than LABD?
Dividends
Dividend Payout History
Ex-Div Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2026-03-24 | 2026-03-24 | 2026-03-31 | 0.085 |
| 2025-12-23 | 2025-12-23 | 2025-12-31 | 0.229 |
| 2025-09-23 | 2025-09-23 | 2025-09-30 | 0.026 |
| 2025-06-24 | 2025-06-24 | 2025-07-01 | 0.037 |
| 2025-03-25 | 2025-03-25 | 2025-04-01 | 0.055 |
| 2024-12-23 | 2024-12-23 | 2024-12-31 | 0.126 |
| 2024-09-24 | 2024-09-24 | 2024-10-01 | 0.058 |
Show more
How Much Does LABD Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy LABD?
Fund Flows
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
